Resultados globales: 6 registros encontrados en 0.02 segundos.
Artículos, Encontrados 6 registros
Artículos Encontrados 6 registros  
1.
6 p, 255.0 KB Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer : Supporting personalised screening / Román, M. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Quintana Ruiz, Maria Jesús (Institut d'Investigació Biomèdica Sant Pau) ; Ferrer, J. (Parc Hospitalari Martí i Julià) ; Sala, M. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Castells, X. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Universitat Autònoma de Barcelona
Our aim was to assess the cumulative risk of false-positive screening results, screen-detected cancer, and interval breast cancer in mammography screening among women with and without a previous benign breast disease and a family history of breast cancer. [...]
2017 - 10.1038/bjc.2017.107
British Journal of Cancer, Vol. 116 Núm. 11 (23 2017) , p. 1480-1485  
2.
9 p, 2.4 MB HPIPred : Host-pathogen interactome prediction with phenotypic scoring / Macho Rendón, Javier (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Rebollido-Ríos, Rocio (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Torrent Burgas, Marc (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Protein-protein interactions (PPIs) are involved in most cellular processes. Unfortunately, current knowledge of host-pathogen interactomes is still very limited. Experimental methods used to detect PPIs have several limitations, including increasing complexity and economic cost in large-scale screenings. [...]
2022 - 10.1016/j.csbj.2022.11.026
Computational and Structural Biotechnology Journal, Vol. 20 (november 2022) , p. 6534-6542  
3.
16 p, 581.3 KB Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer : a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) / Canelo Aybar, Carlos Gilberto (Institut d'Investigació Biomèdica Sant Pau) ; Posso, M. (Hospital del Mar (Barcelona, Catalunya)) ; Montero, N. (Centro Cochrane Iberoamericano) ; Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Saz-Parkinson, Zuleika (European Commission. Joint Research Centre (JRC)) ; Duffy, Stephen W (Wolfson Institute of Preventive Medicine. Queen Mary University of London) ; Follmann, M. (German Cancer Society) ; Gräwingholt, A. (Radiologie am Theater) ; Giorgi Rossi, P. (Epidemiology Unit. Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia) ; Alonso-Coello, Pablo (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Universitat Autònoma de Barcelona
Background: Although mammography screening is recommended in most European countries, the balance between the benefits and harms of different screening intervals is still a matter of debate. This review informed the European Commission Initiative on Breast Cancer (BC) recommendations. [...]
2022 - 10.1038/s41416-021-01521-8
British Journal of Cancer, Vol. 126 Núm. 4 (september 2022) , p. 673-688  
4.
12 p, 2.0 MB A multicentre validation study of the diagnostic value of plasma neurofilament light / Ashton, Nicholas J. (NIHR Biomedical Research Centre for Mental Health (Londres, Regne Unit)) ; Janelidze, Shorena (Clinical Memory Research Unit. Department of Clinical Sciences Malmö. Lund University) ; Al Khleifat, Ahmad (Department of Basic and Clinical Neuroscience. Maurice Wohl Clinical Neuroscience Institute. King's College London) ; Leuzy, Antoine (Clinical Memory Research Unit. Department of Clinical Sciences Malmö. Lund University) ; van der Ende, Emma L. (Alzheimer Center Rotterdam and Dept. of Neurology. Erasmus University Medical Center) ; Karikari, Thomas K (Department of Psychiatry and Neurochemistry. Institute of Neuroscience & Physiology. The Sahlgrenska Academy at the University of Gothenburg) ; Benedet, AndreaL. (Montreal Neurological Institute) ; Pascoal, Tharick A. (Montreal Neurological Institute) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Parnetti, Lucilla (Laboratory of Clinical Neurochemistry. Neurology Clinic. University of Perugia) ; Galimberti, Daniela (University of Milan) ; Bonanni, Laura (Department of Neuroscience. Imaging and Clinical Sciences. University G.d'Annunzio of Chieti-Pescara) ; Pilotto, Andrea (Parkinson's Disease Rehabilitation Centre. FERB ONLUS) ; Padovani, Alessandro (Neurology Unit. Department of Clinical and Experimental Sciences. University of Brescia) ; Lycke, Jan (Sahlgrenska University Hospital (Suècia)) ; Novakova, Lenka (Sahlgrenska University Hospital (Suècia)) ; Axelsson, Markus (Sahlgrenska University Hospital (Suècia)) ; Velayudhan, Latha (Department of Health Sciences. University of Leicester) ; Rabinovici, Gil D. (Department of Radiology & Biomedical Imaging. University of California) ; Miller, Bruce L. (University of California San Francisco. Memory and Aging Center) ; Pariante, Carmine M (Stress. Psychiatry and Immunology Lab & Perinatal Psychiatry. Maurice Wohl Clinical Neuroscience Institute. King's College London) ; Nikkheslat, Naghmeh (King's College London (Regne Unit)) ; Resnick, Susan M. (Brain Aging and Behavior Section. Laboratory of Behavioral Neuroscience. National Institute on Aging. National Institutes of Health) ; Thambisetty, Madhav (Clinical and Translational Neuroscience Section. Laboratory of Behavioral Neuroscience. National Institute on Aging. National Institutes of Health) ; Schöll, Michael (Department of Neurodegenerative Disease. Queen Square Institute of Neurology. University College London) ; Fernández-Eulate, Gorka (Department of Neurology. Donostia University Hospital. Osakidetza) ; Gil-Bea, Francisco J. (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; López de Munain, Adolfo (Universidad del País Vasco. Departamento de Neurociencias) ; Al-Chalabi, Ammar (King's College Hospital NHS Foundation Trust) ; Rosa-Neto, Pedro (Montreal Neurological Institute) ; Strydom, Andre (London Down Syndrome Consortium (LonDowns)) ; Svenningsson, Per (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ; Stomrud, Erik (Skåne University Hospital (Suècia)) ; Santillo, Alexander (Lund University. Department of Clinical Sciences Malmö) ; Aarsland, Dag (Stavanger University Hospital) ; van Swieten, John C. (Erasmus University Medical Center) ; Palmqvist, Sebastian (Lund University. Skåne University Hospital) ; Zetterberg, Henrik (University College London. UK Dementia Research Institute) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Hye, Abdul (Stavanger University Hospital) ; Hansson, Oskar (Skåne University Hospital (Suècia))
Increased cerebrospinal fluid neurofilament light (NfL) is a recognized biomarker for neurodegeneration that can also be assessed in blood. Here, we investigate plasma NfL as a marker of neurodegeneration in 13 neurodegenerative disorders, Down syndrome, depression and cognitively unimpaired controls from two multicenter cohorts: King's College London (n = 805) and the Swedish BioFINDER study (n = 1,464). [...]
2021 - 10.1038/s41467-021-23620-z
Nature communications, Vol. 12 Núm. 1 (january 2021) , p. 3400  
5.
8 p, 256.7 KB Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening / Román, R. (Institut Municipal d'Investigació Mèdica (Barcelona, Catalunya)) ; Sala, Maria (Institut Municipal d'Investigació Mèdica (Barcelona, Catalunya)) ; Salas, D. (Centre Superior d'Investigació en Salut Pública, València) ; Ascunce, Nieves (Instituto de Salud Pública de Navarra) ; Zubizarreta Alberdi, Raquel (Conselleria de Sanidade de la Xunta de Galicia) ; Castells, Xavier (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Background: Reducing the false-positive risk in breast cancer screening is important. We examined how the screening-protocol and women's characteristics affect the cumulative false-positive risk. Methods: This is a retrospective cohort study of 1 565 364 women aged 45-69 years who underwent 4 739 498 screening mammograms from 1990 to 2006. [...]
2011 - 10.1093/annonc/mdr032
Annals of oncology, Vol. 23 (march 2011) , p. 104-111  
6.
8 p, 111.9 KB El conflicto armado en Colombia : aproximación a la memoria histórica a partir del cine / Agudelo Ramírez, Martín (Universidad Pontificia Bolivariana)
Son muchos los proyectos fílmicos recientes en los que se muestra la cruenta realidad que ha irrumpido en un país constantemente atormentado por el olvido de sus habitantes, y en donde aparecen comprometidos su fuerza pública, guerrilla y paramilitares, en medio de una población civil que resulta ser la gran damnificada, debido a diferentes causas como: 'falsos positivos', desplazamientos forzados, desapariciones y reclutamientos indebidos de menores.
Many recent films made in Colombia allow us to understand the tragedy of conflict in this country constantly tormented by violence. Colombians need memory, because wars are a great tragedy. The victimizer, guerrillas and paramilitaries, committed serious violations of human rights ('false positives', forced displacements, disappearances, illicit recruitings of underaged). [...]

2017
DeSignis, Núm. 27 (Julio-Diciembre 2017) , p. 119-133  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.